Cargando…

MAPK signaling regulates the efficacy of chemoimmunotherapy

Resistance to chemoimmunotherapy is a major issue for cancer care. We recently unravelled the role of mitogen-activated protein kinase (MAPK) to limit the antitumor efficacy of such combination. Inhibitor of MAPK pathway using mitogen-activated protein kinase (MEK) inhibitor in combination with chem...

Descripción completa

Detalles Bibliográficos
Autor principal: Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067517/
https://www.ncbi.nlm.nih.gov/pubmed/35529902
http://dx.doi.org/10.1080/23723556.2022.2054652

Ejemplares similares